Antibodies directed against a LDL receptor

Details for Australian Patent Application No. 2006274751 (hide)

Owner Laboratoire Francois du Fractionnement et des Biotechnologies Groupement D' Interet Public

Inventors Najib, Jamila; Behrens, Christian; Prost, Jean-Francois; Gaucher, Christine

Agent Griffith Hack

Pub. Number AU-A-2006274751

PCT Pub. Number WO2007/014991

Priority 0508282 03.08.05 FR

Filing date 25 July 2006

Wipo publication date 8 February 2007

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/014991 Priority application(s): WO2007/014991

10 April 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Laboratoire Francois du Fractionnement et des Biotechnologies Groupement D' Interet Public, Application No. 2006274751, under INID (71) correct the name to read Laboratoire Francais du Fractionnement et des Biotechnologies Groupement D' Interet Public Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Jo

28 August 2008 Section 223 Application Received

  Laboratoire Francais du Fractionnement et des Biotechnologies Groupement D' Interet Public An application to extend the time from 08 Feb 2007 to 08 Mar 2008 in which to comply with Section 6(c) has been filed . Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 Extensions of Time, Section 223 2008

28 August 2008 Section 223 Application Allowed

  Laboratoire Francais du Fractionnement et des Biotechnologies Groupement D' Interet Public The time in which to lodge a Statutory Declaration has been extended to 12 Aug 2008. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004

16 October 2008 Section 223 Application Allowed

  Laboratoire Francais du Fractionnement et des Biotechnologies Groupement D' Interet Public The time in which to comply with Section 6(c) has been extended to 08 Mar 2008. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004 2007

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006274752-Antibodies directed against an LDL receptor

2006274748-Gangway apparatus